On the public citation graph

https://doi.org/10.2139/ssrn.4677555

0 signed · 43 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/eji.201545696openalex-extracted
IL‐33 promotes innate IFN‐γ production and modulates dendritic cell response in LCMV‐induced hepatitis in mice
inferredcites →https://doi.org/10.1016/j.cell.2020.04.026openalex-extracted
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
inferredcites →https://doi.org/10.1016/j.celrep.2022.110829openalex-extracted
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
inferredcites →https://doi.org/10.1016/j.immuni.2005.09.015openalex-extracted
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
inferredcites →https://doi.org/10.1016/j.jaci.2014.05.011openalex-extracted
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
inferredcites →https://doi.org/10.1016/j.jhep.2011.03.022openalex-extracted
Protective role of IL-33/ST2 axis in Con A-induced hepatitis
inferredcites →https://doi.org/10.1016/j.rmed.2018.05.016openalex-extracted
Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma
inferredcites →https://doi.org/10.1016/s2213-2600(21)00081-3openalex-extracted
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
inferredcites →https://doi.org/10.1016/s2213-2600(21)00377-5openalex-extracted
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
inferredcites →https://doi.org/10.1038/cmi.2017.147openalex-extracted
IL-33 induces immunosuppressive neutrophils via a type 2 innate lymphoid cell/IL-13/STAT6 axis and protects the liver against injury in LCMV infection-induced viral hepatitis
inferredcites →https://doi.org/10.1038/nri.2016.95openalex-extracted
Interleukin-33 in health and disease
inferredcites →https://doi.org/10.1038/s41392-021-00679-0openalex-extracted
The signal pathways and treatment of cytokine storm in COVID-19
inferredcites →https://doi.org/10.1038/s41423-021-00685-wopenalex-extracted
IL-33 in COVID-19: friend or foe?
inferredcites →https://doi.org/10.1038/s41467-021-22449-wopenalex-extracted
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
inferredcites →https://doi.org/10.1038/s41577-019-0215-7openalex-extracted
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
inferredcites →https://doi.org/10.1038/s41586-022-05542-yopenalex-extracted
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
inferredcites →https://doi.org/10.1038/s41590-021-01097-8openalex-extracted
Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity
inferredcites →https://doi.org/10.1056/nejmc2011400openalex-extracted
Multiorgan and Renal Tropism of SARS-CoV-2
inferredcites →https://doi.org/10.1056/nejmoa2028836openalex-extracted
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
inferredcites →https://doi.org/10.1056/nejmra2026131openalex-extracted
Cytokine Storm
inferredcites →https://doi.org/10.1073/pnas.1315854111openalex-extracted
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
inferredcites →https://doi.org/10.1093/bioinformatics/bts356openalex-extracted
RSeQC: quality control of RNA-seq experiments
inferredcites →https://doi.org/10.1093/bioinformatics/btu638openalex-extracted
HTSeq—a Python framework to work with high-throughput sequencing data
inferredcites →https://doi.org/10.1111/imm.13404openalex-extracted
IL‐33 activates mTORC1 and modulates glycolytic metabolism in CD8+ T cells
inferredcites →https://doi.org/10.1111/imr.12552openalex-extracted
IL ‐33: biological properties, functions, and roles in airway disease
inferredcites →https://doi.org/10.1111/imr.12619openalex-extracted
Interleukin‐33 ( IL ‐33): A nuclear cytokine from the IL ‐1 family
inferredcites →https://doi.org/10.1126/science.1215418openalex-extracted
The Alarmin Interleukin-33 Drives Protective Antiviral CD8 + T Cell Responses
inferredcites →https://doi.org/10.1128/mbio.02979-21openalex-extracted
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
inferredcites →https://doi.org/10.1146/annurev-immunol-101320-124243openalex-extracted
Emerging Functions of IL-33 in Homeostasis and Immunity
inferredcites →https://doi.org/10.1183/13993003.01870-2021openalex-extracted
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)
inferredcites →https://doi.org/10.1186/s12985-022-01814-1openalex-extracted
COVID-19 infection: an overview on cytokine storm and related interventions
inferredcites →https://doi.org/10.1186/s13059-014-0550-8openalex-extracted
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
inferredcites →https://doi.org/10.1186/s13223-023-00810-6openalex-extracted
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive
inferredcites →https://doi.org/10.1186/s43088-023-00367-8openalex-extracted
Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
inferredcites →https://doi.org/10.1371/journal.pbio.3001284openalex-extracted
Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
inferredcites →https://doi.org/10.2217/bmm-2020-0410openalex-extracted
Serum-Soluble St2 As A Novel Biomarker Reflecting Inflammatory Status and Illness Severity in Patients with Covid-19
inferredcites →https://doi.org/10.3201/eid2606.200516openalex-extracted
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
inferredcites →https://doi.org/10.3389/fimmu.2021.667922openalex-extracted
c-Rel Is Required for IL-33-Dependent Activation of ILC2s
inferredcites →https://doi.org/10.3389/fimmu.2021.675169openalex-extracted
Role of ILC2 in Viral-Induced Lung Pathogenesis
inferredcites →https://doi.org/10.3389/fmed.2021.749569openalex-extracted
IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding
inferredcites →https://doi.org/10.3390/ijms232113656openalex-extracted
Emerging Effects of IL-33 on COVID-19
inferredcites →https://doi.org/10.3390/ijms232314532openalex-extracted
IL-33 and the Cytokine Storm in COVID-19: From a Potential Immunological Relationship towards Precision Medicine
inferredcites →https://doi.org/10.4049/jimmunol.1300117openalex-extracted
IL-33 Induces Nuocytes and Modulates Liver Injury in Viral Hepatitis
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.